Bionor Holding AS
https://bionorholding.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Bionor Holding AS
Appointments: New CEO For Silence Therapeutics, Medical Heads Join Merck, Breath Therapeutics, Immusoft
David Solomon’s entrance as Silence Therapeutics’ new CEO leads this week’s new hires. While Ireland-based Malin shakes up its board of directors, other execs join Merck, Apeiron Biologics, Vectura, Roivant, OncoSec, Breath Therapeutics, Immusoft and M3 Biotechnology.
Appointments: Shire, Novartis, BenevolentAI, Akari Therapeutics and NDA
This week's roundup includes some movement in big pharma with the appointment of a chief financial officer by Shire, a chief digital officer by Novartis and BenevolentAI hiring GSK's head of a discovery performance unit.
Akari Taps Zealand Ex-CEO Solomon To Reboot Tick-Based Group's Prospects
Struggling to restore investor confidence amid controversy, Akari has convinced former Zealand CEO David Solomon to take on the same role there and try to re-energize the NY-based biotech.
Encouraging HIV 'Cure' Data Strengthen Abivax
Hepatitis C is effectively cured. Could this success be replicated in another serious chronic viral condition ‒ HIV? Abivax, which last year abandoned its hepatitis B lead program, has bounced back with data suggesting a 'functional cure' for HIV is more than just a pipe dream.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Nutraceuticals
- Vaccines
- Other Names / Subsidiaries
-
- Bionor Immuno AS
- Bionor Pharma ASA
- Nutri Pharma ASA
- Bionor Holding AS
- Bionor Pharma AS
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice